382 related articles for article (PubMed ID: 28591133)
1. Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms.
Lambert MNT; Thorup AC; Hansen ESS; Jeppesen PB
PLoS One; 2017; 12(6):e0176590. PubMed ID: 28591133
[TBL] [Abstract][Full Text] [Related]
2. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
3. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial.
Lambert MNT; Thybo CB; Lykkeboe S; Rasmussen LM; Frette X; Christensen LP; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):909-920. PubMed ID: 28768651
[No Abstract] [Full Text] [Related]
4. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
Speroff L; Gass M; Constantine G; Olivier S;
Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
[TBL] [Abstract][Full Text] [Related]
5. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
[TBL] [Abstract][Full Text] [Related]
6. Phytoestrogens for vasomotor menopausal symptoms.
Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Clinical Meaningfulness of Red Clover (
Kanadys W; Barańska A; Błaszczuk A; Polz-Dacewicz M; Drop B; Kanecki K; Malm M
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920485
[TBL] [Abstract][Full Text] [Related]
8. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
9. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.
van de Weijer PH; Barentsen R
Maturitas; 2002 Jul; 42(3):187-93. PubMed ID: 12161042
[TBL] [Abstract][Full Text] [Related]
10. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165].
Atkinson C; Warren RM; Sala E; Dowsett M; Dunning AM; Healey CS; Runswick S; Day NE; Bingham SA
Breast Cancer Res; 2004; 6(3):R170-9. PubMed ID: 15084240
[TBL] [Abstract][Full Text] [Related]
11. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women.
Lipovac M; Chedraui P; Gruenhut C; Gocan A; Kurz C; Neuber B; Imhof M
Gynecol Endocrinol; 2012 Mar; 28(3):203-7. PubMed ID: 21870906
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the symptomatic response in Indian menopausal women with different estrogen preparations for the treatment of menopausal symptoms: a randomized controlled trial.
Malik S; Pannu D; Prateek S; Sinha R; Gaikwad H
Arch Gynecol Obstet; 2016 Jun; 293(6):1325-33. PubMed ID: 26884352
[TBL] [Abstract][Full Text] [Related]
13. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial.
Ye YB; Wang ZL; Zhuo SY; Lu W; Liao HF; Verbruggen M; Fang S; Mai HY; Chen YM; Su YX
Menopause; 2012 Jul; 19(7):791-8. PubMed ID: 22278344
[TBL] [Abstract][Full Text] [Related]
14. Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis.
Myers SP; Vigar V
Phytomedicine; 2017 Jan; 24():141-147. PubMed ID: 28160855
[TBL] [Abstract][Full Text] [Related]
15. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment.
St Germain A; Peterson CT; Robinson JG; Alekel DL
Menopause; 2001; 8(1):17-26. PubMed ID: 11201510
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.
Depypere H; Timmerman D; Donders G; Sieprath P; Ramael S; Combalbert J; Hoveyda HR; Fraser GL
J Clin Endocrinol Metab; 2019 Dec; 104(12):5893-5905. PubMed ID: 31415087
[TBL] [Abstract][Full Text] [Related]
17. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
[TBL] [Abstract][Full Text] [Related]
18. Phytoestrogens for treatment of menopausal symptoms: a systematic review.
Krebs EE; Ensrud KE; MacDonald R; Wilt TJ
Obstet Gynecol; 2004 Oct; 104(4):824-36. PubMed ID: 15458907
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
[TBL] [Abstract][Full Text] [Related]
20. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation.
Knight DC; Howes JB; Eden JA; Howes LG
Climacteric; 2001 Mar; 4(1):13-8. PubMed ID: 11379373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
